2.Follicular immunoblastic lymphoma: a clinicopathologic and immunohistochemical study of a case.
Xuanqiu HE ; Lei YANG ; Yanqing DING
Journal of Southern Medical University 2013;33(6):794-797
Primary follicular immunoblastic lymphoma (FIBL) is an extremely rare lymphoma. The positive expression of CD10 suggests the lymphoma originating from germinal centers (GC) and CD138-positive expression generally indicates plasmablastic or plasmacytic differentiation. We report such a rare case in a Chinese female patient and analyze the clinicopathologic and immunohistochemical features of this disease. PET-CT examination was performed to detect signs of systemic lymph node metastasis. We also discussed the differential diagnosis of FIBL from follicular lymphoma (FL) and reactive follicular hyperplasia (RFH). As a rare variant of human follicular lymphoma, FIBL is featured by a neoplastic overgrowth of intrafollicular immunoblasts. Compared with FL, FIBL has a greater chance to evolve into diffuse large B-cell lymphoma with therefore a poorer prognosis.
Adult
;
Female
;
Humans
;
Immunoblastic Lymphadenopathy
;
pathology
;
Lymphoma, Follicular
;
pathology
3.Update knowledge about the classification of lymphomas.
Chinese Journal of Pathology 2013;42(9):577-579
4.Histologic evaluation of malignant lymphoma.
Chinese Journal of Pathology 2011;40(4):217-219
Dendritic Cells, Follicular
;
pathology
;
Diagnosis, Differential
;
Humans
;
Leukemia, Lymphocytic, Chronic, B-Cell
;
pathology
;
Lymphoma
;
pathology
;
Lymphoma, Extranodal NK-T-Cell
;
pathology
;
Lymphoma, Follicular
;
pathology
;
Lymphoma, Large B-Cell, Diffuse
;
pathology
;
Lymphoma, Large-Cell, Anaplastic
;
pathology
;
Lymphoma, Mantle-Cell
;
pathology
;
Lymphoma, T-Cell, Peripheral
;
pathology
;
Neoplasm Invasiveness
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
pathology
5.Clinical manifestation of lymphoma and its significance in pathological diagnosis.
Xiao-ge ZHOU ; Jian-lan XIE ; Yan JIN ; Yuan-yuan ZHENG
Chinese Journal of Pathology 2012;41(1):57-58
Burkitt Lymphoma
;
diagnosis
;
pathology
;
Female
;
Hodgkin Disease
;
diagnosis
;
pathology
;
Humans
;
Lymphoma
;
classification
;
diagnosis
;
pathology
;
Lymphoma, Extranodal NK-T-Cell
;
diagnosis
;
pathology
;
Lymphoma, Follicular
;
diagnosis
;
pathology
;
Lymphoma, Large B-Cell, Diffuse
;
diagnosis
;
pathology
;
Male
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
diagnosis
;
pathology
6.Follicular lymphoma with a predominantly diffuse growth pattern with 1p36 deletion: a clinicopathologic analysis of eight cases.
J ZHOU ; J L XIE ; X G ZHOU ; X J ZHOU ; Q X XIA
Chinese Journal of Pathology 2024;53(1):34-39
Objective: To investigate the clinical and pathologic features and diagnosis of follicular lymphoma (FL) with a predominantly diffuse growth pattern (DFL) with 1p36 deletion. Methods: Eight cases of DFL with 1p36 deletion diagnosed at Department of Pathology, Beijing Friendship Hospital, Capital Medical University (n=5) and the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital (n=3) from January 2017 to January 2023 were included. Their clinicopathologic features and follow-up data were analyzed. Immunohistochemistry and fluorescence in situ hybridization (FISH) were performed. Results: There were five males and three females, with a median age of 67 years, and inguinal lymphadenopathy was found as the main symptom. Histologically, similar morphologic features were sheared among all cases, with effaced nodal structure and characterized by proliferation of centrocytes in a diffuse pattern, with or without follicular components. The germinal center-related markers such as CD10 and/or bcl-6 were expressed in the tumor cells, and 1p36 deletion but not bcl-2 translocation was appreciable in these cases. Conclusions: DFL with 1p36 deletion is a rare subtype of FL, with some overlaps with other types of FL or indolent B-cell lymphomas in their pathologic features. An accurate diagnosis requires comprehensive considerations based on their clinical, pathologic, immunohistochemical, and molecular features.
Male
;
Female
;
Humans
;
Aged
;
Lymphoma, Follicular/pathology*
;
In Situ Hybridization, Fluorescence
;
Lymphoma, B-Cell/pathology*
;
Chromosome Deletion
;
Cell Proliferation
7.Clinical Research Advances of Duodenal-Type Follicular Lymphoma--Review.
Hong-Yi LI ; Jun-Dong ZHANG ; Xue-Chun LU
Journal of Experimental Hematology 2023;31(2):581-584
Duodenal-type follicular lymphoma (DFL) is a unique subtype of follicular lymphoma (FL), which often involves the second portion of duodenum (descending part of duodenum). Due to its specific pathological features, such as lack of follicular dendritic cells meshwork and disappearance of activation-induced cytidine deaminase expression, DFL presents an inert clinical course and is often confined to the intestinal tract. Inflammation-related biomarkers suggest that the microenvironment may play a likely role in the pathogenesis and favorable prognosis of DFL. Since patients generally have no obvious clinical symptoms and low progression rate, the treatment regimen for DFL is mainly observation and waiting (W&W) strategy. This study will review the latest research progress of epidemiology, diagnosis, treatment and prognosis of DFL in recent years.
Humans
;
Lymphoma, Follicular/drug therapy*
;
Duodenal Neoplasms/pathology*
;
Prognosis
;
Tumor Microenvironment
8.Clinicopathological analysis of 64 case of angioimmunoblastic T-cell lymphoma.
Congyou GU ; Nan LI ; Min LI ; Xuemin XUE ; Zifen GAO
Chinese Journal of Hematology 2014;35(1):24-28
OBJECTIVETo explore the clinical and pathological characteristics of angioimmunoblastic T-cell lymphoma (AITL).
METHODSSixty-four cases of AITL were retrospectively analyzed by histopathological and immunohistochemical methods.
RESULTSThere were 35 men and 29 women, the median age was 59 years (range, 25-84 ys). AITL typically presented with advanced stage, generalized lymphadenopathy, hepatosplenomegaly and systemic symptoms. Morphologically, the lymph nodes showed partial or total obliteration of the normal architecture by a polymorphic infiltration of lymphocytes, and by proliferation of follicular dendritic cells and that of high endothelial venules. Most cases contained a monoclonal T-cell population as well as clonal cytogenetic abnormalities. Immunophenotype analysis showed that neoplastic cells expressed the following markers: CXCL13 (positive rate 95.3%), PD-1 (positive rate 75.0%), CD10 (positive rate 25.0%), Bcl- 6 (positive rate 40.0%), CD2 (positive rate 96.0%), CD3 (positive rate 95.0%), CD4 (positive rate 84.0%), CD5 (positive rate 73.0%), EBER (positive rate 39.5%) and Ki-67 (average positive rate 55.0%), and frequently showed aberrant loss or reduced expression of CD7 and CD8.
CONCLUSIONThe neoplastic cells of AITL showed features of CD4+ TFH, with peculiar clinical features. Peripheral T-cell lymphomas with a follicular growth pattern may show overlapping features with focal AITL.
Adult ; Aged ; Aged, 80 and over ; Diagnosis, Differential ; Female ; Humans ; Immunoblastic Lymphadenopathy ; diagnosis ; pathology ; Lymphoma, Follicular ; pathology ; Lymphoma, T-Cell, Peripheral ; diagnosis ; pathology ; Male ; Middle Aged ; Retrospective Studies
9.Pathogenesis of follicular lymphoma.
Pei-hong ZHANG ; Xiong-zeng ZHU
Chinese Journal of Pathology 2007;36(1):56-58
Chromosomes, Human, Pair 14
;
Chromosomes, Human, Pair 18
;
Dendritic Cells, Follicular
;
metabolism
;
pathology
;
Humans
;
Lymphoma, Follicular
;
genetics
;
metabolism
;
pathology
;
Lymphoma, Large B-Cell, Diffuse
;
genetics
;
metabolism
;
pathology
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
;
Translocation, Genetic
10.Update on relation between follicular helper T cells and lymphoma.
Chinese Journal of Pathology 2013;42(9):634-637
Biomarkers, Tumor
;
metabolism
;
Humans
;
Immunoblastic Lymphadenopathy
;
metabolism
;
pathology
;
Lymphoma
;
genetics
;
metabolism
;
pathology
;
Lymphoma, Follicular
;
genetics
;
metabolism
;
pathology
;
Lymphoma, T-Cell, Peripheral
;
genetics
;
metabolism
;
pathology
;
Signal Transduction
;
Skin Neoplasms
;
metabolism
;
pathology
;
T-Lymphocytes, Helper-Inducer
;
metabolism
;
pathology